{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":856,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":856,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"432dfe733d98","filters":{"venue":"British Journal of Cancer"}},"results":[{"id":"W2115785123","doi":"10.1038/sj.bjc.6605642","title":"Guidelines for the welfare and use of animals in cancer research","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":1445,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"National Centre for the Replacement, Refinement and Reduction of Animals in Research; University of Leicester; Cancer Research UK; AstraZeneca","keywords":"Medicine; Cancer; Underpinning; Animal welfare; Animal testing; Welfare; Intensive care medicine; Medical physics; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.5279977563874871,"gpt":0.5586178454881463,"spread":0.03062008910065916,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009828763,0.00005491373,0.0001659867,0.00006525039,0.000106975,0.00006939162,0.0001676204,0.00003649803,0.0001334961],"category_scores_gemma":[0.00152605,0.00004313099,0.00004873861,0.0001023513,0.0001486656,0.000145811,0.00004601129,0.0003772805,1.478229e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001851446,"about_ca_system_score_gemma":0.00008689566,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00880178,"about_ca_topic_score_gemma":0.006738605,"domain_scores_codex":[0.9990947,0.0000567879,0.0003636126,0.00009289161,0.000232096,0.0001598656],"domain_scores_gemma":[0.9979885,0.000452726,0.0001968673,0.00006165081,0.001258012,0.00004221447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001541277,0.00009746445,0.0959991,0.0001663897,0.0001473802,0.0003572827,0.0005259466,0.000109081,0.1043129,0.0006134884,0.01700473,0.7791249],"study_design_scores_gemma":[0.001325128,0.0008690393,0.7533348,0.001607143,0.00003488895,0.001315022,0.0006192131,0.0007269737,0.001709511,0.000691413,0.2376089,0.0001578907],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977518,0.01914666,0.00001748123,0.002863076,0.0002171105,0.0001134318,0.00007913686,0.000002937309,0.00004220837],"genre_scores_gemma":[0.9926503,0.004786752,0.001708501,0.00006018192,0.0005735623,0.00002090208,1.180426e-7,0.00001371359,0.0001860188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.778967,"threshold_uncertainty_score":0.9977987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1565078991","doi":"10.1038/bjc.2015.190","title":"A clinically applicable molecular-based classification for endometrial cancers","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":944,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Foundation","keywords":"Oncology; Internal medicine; Endometrial cancer; Survival analysis; Immunohistochemistry; Biology; Bioinformatics; Medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.07945659241102301,"gpt":0.3865245606110878,"spread":0.3070679682000648,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006724212,0.0001132251,0.0005129852,0.0001525388,0.00003979847,0.00004668668,0.0001293733,0.0001037366,0.0001326356],"category_scores_gemma":[0.0008751333,0.0001081335,0.000335,0.0004737311,0.00005954543,0.00008331758,0.00001046914,0.0002105536,0.000003854224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006978427,"about_ca_system_score_gemma":0.001736164,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005470103,"about_ca_topic_score_gemma":0.000100808,"domain_scores_codex":[0.9982634,0.00004677728,0.0007055512,0.0001832187,0.0005634016,0.0002376515],"domain_scores_gemma":[0.9978147,0.0002022583,0.0004715496,0.0001182896,0.0009483819,0.0004448802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02398804,0.0007949147,0.01864552,0.0001872988,0.0008567767,0.0004388365,0.0000370193,0.001004209,0.004376815,0.0001504107,0.01552174,0.9339984],"study_design_scores_gemma":[0.2451317,0.01559734,0.03509648,0.002333469,0.003543559,0.001306435,0.0004416446,0.001732336,0.02161971,0.003146861,0.6690961,0.000954353],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8732976,0.05574803,0.0486558,0.006516155,0.004544005,0.002982265,0.0003483086,0.00008369949,0.007824165],"genre_scores_gemma":[0.9889298,0.000830519,0.006632356,0.001631985,0.001492437,0.000176385,0.00001628353,0.00003227034,0.0002579709],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9330441,"threshold_uncertainty_score":0.4409556,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143584015","doi":"10.1038/sj.bjc.6601887","title":"High levels of untreated distress and fatigue in cancer patients","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":941,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Cancer Foundation","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psychosocial; Distress; Anxiety; Depression (economics); Lung cancer; Social support; Prostate cancer; Breast cancer; Cancer; Internal medicine; Psychiatry; Clinical psychology; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.01943273918371258,"gpt":0.2948988533097637,"spread":0.2754661141260511,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007299133,0.00008447475,0.0003521395,0.0000800112,0.00001878232,0.00001475608,0.00005720001,0.00005836393,0.0002556717],"category_scores_gemma":[0.00003170913,0.00008552642,0.00006066827,0.0001776557,0.00006662658,0.0001032526,0.00001477668,0.0001857347,1.487533e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002232821,"about_ca_system_score_gemma":0.0002157554,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04344763,"about_ca_topic_score_gemma":0.07367243,"domain_scores_codex":[0.9990655,0.00002021279,0.0003825306,0.0001010263,0.0002874043,0.0001433164],"domain_scores_gemma":[0.9992594,0.00001461442,0.0002270804,0.00005528784,0.0003351373,0.0001085486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004610945,0.000304489,0.6020005,0.0002754872,0.0001494879,0.0003973984,0.0009021267,0.0004124172,0.0005626013,0.00003770605,0.0002395015,0.3942572],"study_design_scores_gemma":[0.005971561,0.0002220876,0.9844406,0.003571982,0.00008885464,0.0001020843,0.0001165014,0.000001269957,0.004522196,0.0001443752,0.0007211402,0.00009734814],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835843,0.01513092,0.00001635946,0.0003337942,0.0004190266,0.00009864334,0.0002993468,0.000003225261,0.0001143266],"genre_scores_gemma":[0.9948609,0.004715114,0.00003731767,0.0001442769,0.0001454308,0.000006985743,0.000004758921,0.00001355808,0.00007167616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3941598,"threshold_uncertainty_score":0.9629222,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977392502","doi":"10.1054/bjoc.2000.1316","title":"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":939,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Temozolomide; Medicine; Procarbazine; Internal medicine; Chemotherapy; Adverse effect; Quality of life (healthcare); Phases of clinical research; Cancer; Dacarbazine; Progression-free survival; Oncology; Surgery; Vincristine; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.00595770731350117,"gpt":0.2567829562355224,"spread":0.2508252489220213,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009632456,0.0001293812,0.0004910762,0.0001300751,0.0000730172,0.00001090012,0.00006940465,0.00004263438,0.0005291022],"category_scores_gemma":[0.00002954834,0.0001061375,0.00007599219,0.00024235,0.00003943828,0.0001270533,0.00001991626,0.0001574327,0.000003065896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002763383,"about_ca_system_score_gemma":0.00008157838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007690386,"about_ca_topic_score_gemma":0.01078133,"domain_scores_codex":[0.9986073,0.00002307664,0.0005559064,0.0001494142,0.0004688925,0.0001954014],"domain_scores_gemma":[0.99919,0.00002244057,0.0002899746,0.0001145949,0.0002427293,0.0001402471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01295465,0.02652584,0.8121233,0.00005234106,0.0003371708,0.002279524,0.0007843315,0.0001629854,0.00004012655,1.380614e-7,0.001565571,0.143174],"study_design_scores_gemma":[0.09150997,0.03393143,0.8676962,0.001888698,0.0002849317,0.0005385004,0.00008580096,0.00001802958,0.0007577658,0.000001302091,0.003172647,0.0001146964],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972417,0.001757587,1.14961e-7,0.0001756286,0.00005137589,0.000647069,0.00002948854,0.000005278845,0.00009171502],"genre_scores_gemma":[0.9990013,0.0005923529,0.00006461917,0.00006871925,0.00005689139,0.00004424519,0.000003150293,0.00002189207,0.0001467792],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1430593,"threshold_uncertainty_score":0.6016236,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074952360","doi":"10.1038/bjc.2012.451","title":"Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"University of California, San Francisco; University of Texas MD Anderson Cancer Center; U.S. Public Health Service; National Cancer Institute; U.S. Department of Health and Human Services; Science Foundation Ireland; Conquer Cancer Foundation; National Institutes of Health; Stand Up To Cancer; Entertainment Industry Foundation","keywords":"Loss of heterozygosity; Homologous recombination; Ovarian cancer; Biology; Homologous chromosome; Cancer research; Breast cancer; DNA repair; BRCA2 Protein; Genome instability; Cancer; Genetics; Oncology; Allele; DNA; Gene; Medicine; DNA damage; Mutation; Germline mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.01701151675669156,"gpt":0.2972541560484307,"spread":0.2802426392917391,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006840534,0.0001229841,0.0005590813,0.000199521,0.00002771938,0.000006652245,0.0001166942,0.0001263763,0.0006245752],"category_scores_gemma":[0.00005731716,0.0001380949,0.0002431727,0.0001497445,0.00007986455,0.0002371394,0.00002412931,0.0003479181,0.000001077259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005657867,"about_ca_system_score_gemma":0.000339101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003137201,"about_ca_topic_score_gemma":0.001109069,"domain_scores_codex":[0.9981972,0.0001460278,0.0008485314,0.0001337757,0.0003959156,0.0002785652],"domain_scores_gemma":[0.9984515,0.00005548038,0.0008232234,0.0001457604,0.0003784024,0.0001455784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008154996,0.0004570074,0.9438352,0.0003037892,0.0002302982,0.0001560112,0.0004941977,0.0001424326,0.02561756,0.00001706701,0.0005279734,0.02740298],"study_design_scores_gemma":[0.005503068,0.0003487917,0.9546437,0.002275036,0.0001318724,0.001343137,0.00003748447,0.00001465713,0.03444775,0.0001078142,0.001030882,0.0001158056],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.983996,0.013879,0.0001743968,0.000191048,0.001159454,0.000246565,0.0002194973,0.00001216829,0.000121854],"genre_scores_gemma":[0.9894378,0.009292345,0.0002479187,0.0002050944,0.0006849452,0.00002639822,0.000004653263,0.00002703056,0.00007383103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02728718,"threshold_uncertainty_score":0.6838661,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985388571","doi":"10.1038/bjc.2012.350","title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":812,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Health Services; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Sarcopenia; Medicine; Odds ratio; Confidence interval; Rehabilitation; Colorectal cancer; Multivariate analysis; Internal medicine; Inpatient care; Cancer; Physical therapy; Surgery; Health care","retraction":null,"screen_n_in":null,"score":{"opus":0.02848923601270954,"gpt":0.3234195210403475,"spread":0.294930285027638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003944549,0.00008409302,0.0003336756,0.000105989,0.0001390306,0.00004232409,0.00001634522,0.00008894684,0.0006860943],"category_scores_gemma":[0.0001398267,0.00008191366,0.00005976071,0.0001746613,0.00004424975,0.0004266467,0.00000789165,0.0003665189,0.000001340516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004174234,"about_ca_system_score_gemma":0.0003193023,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008956461,"about_ca_topic_score_gemma":0.009636132,"domain_scores_codex":[0.9990147,0.00009778183,0.0003230815,0.00009690072,0.000258221,0.0002093158],"domain_scores_gemma":[0.9988531,0.0001410451,0.0003056564,0.00003017816,0.0004639611,0.000206051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003168026,0.0001886696,0.8818452,0.00005321841,0.0005332755,0.0001321349,0.0006247667,0.000005722881,0.004372267,0.000001218928,0.02998568,0.07908978],"study_design_scores_gemma":[0.002068296,0.0003443528,0.9809319,0.002920131,0.0001742888,0.001241387,0.00007217698,0.00001637068,0.004934778,0.00002239092,0.007159468,0.000114468],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782818,0.01912493,0.00002990251,0.001390196,0.0007900455,0.0001415839,0.00008459136,0.0000121726,0.0001448024],"genre_scores_gemma":[0.9742295,0.02280445,0.0001099728,0.0019019,0.0007546428,0.00001683745,0.0000130697,0.00001882452,0.0001508748],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09908665,"threshold_uncertainty_score":0.997643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2104203198","doi":"10.1054/bjoc.2000.1376","title":"A pooled analysis of magnetic fields and childhood leukaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Electromagnetic Fields and Biological Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":735,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council","keywords":"Relative risk; Confounding; Childhood leukaemia; Medicine; Demography; Estimation; Risk factor; Environmental health; Pediatrics; Confidence interval; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.00251755663583781,"gpt":0.2213361875636635,"spread":0.2188186309278257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001113538,0.00006520396,0.0002256062,0.00003685107,0.00002284061,0.00001542883,0.00009440518,0.000120179,0.0007651813],"category_scores_gemma":[0.00003603023,0.00005868888,0.0001425781,0.0001384852,0.00005349462,0.000002450783,0.00001515228,0.0001105063,2.246858e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003621887,"about_ca_system_score_gemma":0.00003930262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001432941,"about_ca_topic_score_gemma":0.0003413489,"domain_scores_codex":[0.9994172,0.00004155291,0.0002256125,0.0001083216,0.00008921303,0.000118131],"domain_scores_gemma":[0.9996978,0.0000139458,0.00009371063,0.00006541753,0.00007021904,0.00005893028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001388766,0.000092093,0.005846237,0.00001447176,0.0008032289,0.00004107383,0.00002329454,0.0001549523,0.1381101,0.000006397237,0.001208016,0.8535613],"study_design_scores_gemma":[0.002238976,0.008943477,0.9403661,0.0001913134,0.002512929,0.0007354926,0.00002250687,0.000149556,0.03410556,0.000231737,0.0101473,0.0003550321],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9602266,0.03885461,0.00002411697,0.0001227424,0.00002621581,0.00003929684,0.00001067645,0.000001168498,0.0006945539],"genre_scores_gemma":[0.9832337,0.01571863,0.0001565566,0.0003646356,0.0001113541,0.000002010002,0.000004651419,0.000003964655,0.000404431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9345199,"threshold_uncertainty_score":0.8378199,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018971639","doi":"10.1038/sj.bjc.6604554","title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","year":2008,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":651,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Capital District Health Authority","funders":"","keywords":"Warburg effect; Glycolysis; Pyruvate dehydrogenase kinase; Mitochondrion; Pyruvate dehydrogenase complex; Cancer; Anaerobic glycolysis; Cancer cell; Cancer research; Citric acid cycle; Apoptosis; In vivo; Biology; Biochemistry; Medicine; Metabolism; Internal medicine; Enzyme; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02025469186217598,"gpt":0.3297046630877982,"spread":0.3094499712256222,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003382695,0.0004913618,0.00192977,0.0001279533,0.0002056007,0.0001142526,0.0005661615,0.0004511476,0.0001531652],"category_scores_gemma":[0.0001086609,0.0004791552,0.00186091,0.0001711552,0.0001214774,0.00001784857,0.00007488814,0.0004831029,0.000002505636],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005780449,"about_ca_system_score_gemma":0.002226732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005513029,"about_ca_topic_score_gemma":0.0002724749,"domain_scores_codex":[0.997282,0.0001544383,0.001088249,0.000491503,0.0004182018,0.0005656258],"domain_scores_gemma":[0.9974221,0.00002107656,0.001437019,0.0002304399,0.0006369292,0.0002524348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001423929,0.00005409505,0.00000169009,0.0005981163,0.001297221,0.00003417631,0.00001892247,0.00003327537,0.0005744923,0.000003032876,0.03737283,0.9598697],"study_design_scores_gemma":[0.00167093,0.0001332322,0.00001515666,0.002590004,0.0009158302,0.002603844,0.00001052345,0.000001056918,0.0005225394,0.00001681493,0.9909902,0.0005298717],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005763617,0.9915934,0.0001999352,0.00004523704,0.006266915,0.0006886643,0.0005305877,0.000008040144,0.00009086556],"genre_scores_gemma":[0.00003223665,0.9749008,0.0003857267,0.0003390626,0.02213751,0.0003235956,0.0001022312,0.0001584524,0.001620386],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9593399,"threshold_uncertainty_score":0.999766,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151382914","doi":"10.1038/sj.bjc.6604305","title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":535,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"National Health and Medical Research Council; Fondazione Italiana per la Ricerca sul Cancro; Medical Research Council; Hungarian Scientific Research Fund; Helsingin ja Uudenmaan Sairaanhoitopiiri; National Cancer Institute; Office of Defense Programs; Cancer Research UK; U.S. Department of Defense","keywords":"Breast cancer; Population; Ovarian cancer; Oncology; Medicine; Cancer; Demography; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.01194360220042748,"gpt":0.2618691185324316,"spread":0.2499255163320041,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001691104,0.00007841746,0.0001431936,0.00002426466,0.0001740121,0.00002480846,0.0001250065,0.00005545441,0.00001228626],"category_scores_gemma":[0.00005930649,0.00007247926,0.00004537892,0.00006596385,0.0002594047,0.00000735458,0.0000683072,0.0000911715,1.370589e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005425728,"about_ca_system_score_gemma":0.0005463994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005215373,"about_ca_topic_score_gemma":0.003275696,"domain_scores_codex":[0.9992343,0.00003545526,0.0002869496,0.0001606586,0.0001400726,0.0001425648],"domain_scores_gemma":[0.999212,0.00001559379,0.0001514557,0.0001436652,0.0003626808,0.0001145522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0007548852,0.0001034455,0.08013111,0.00007175554,0.0005469903,0.00007574028,0.0008213951,0.02954014,0.4284061,0.00004637,0.03360611,0.4258959],"study_design_scores_gemma":[0.002590155,0.0005706527,0.917525,0.0003805346,0.0002134659,0.01254796,0.0005385272,0.002474865,0.03517846,0.0008890058,0.02653369,0.0005577172],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9681782,0.02986775,0.0009764675,0.0006077828,0.0001197494,0.00009321248,0.0001039732,0.000001417264,0.0000514176],"genre_scores_gemma":[0.9727082,0.02359566,0.003119213,0.0002542175,0.0001827541,0.000008620626,0.000001432945,0.00001260488,0.0001172815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8373938,"threshold_uncertainty_score":0.2955619,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031505107","doi":"10.1038/bjc.2014.215","title":"Oncogenic KRAS signalling in pancreatic cancer","year":2014,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":501,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Deutschen Konsortium für Translationale Krebsforschung; Partenariat Canadien Contre Le Cancer; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"KRAS; Pancreatic cancer; Context (archaeology); Druggability; Cancer research; Cancer; Biology; Pancreatic Intraepithelial Neoplasia; Effector; Medicine; Bioinformatics; Oncology; Internal medicine; Colorectal cancer; Immunology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.06952848065448751,"gpt":0.4345967426747374,"spread":0.3650682620202499,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001343156,0.0003157234,0.004673915,0.0004115405,0.0000600811,0.00004805277,0.0003192866,0.0004466503,0.002159866],"category_scores_gemma":[0.0004010425,0.0002818411,0.0007837641,0.0004336573,0.000139347,0.00008023075,0.00004823111,0.001734753,0.00004100888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001111998,"about_ca_system_score_gemma":0.005030204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001845837,"about_ca_topic_score_gemma":0.001107979,"domain_scores_codex":[0.9964322,0.0003872394,0.001671059,0.0002857296,0.0006947883,0.0005289997],"domain_scores_gemma":[0.9975321,0.0004914556,0.001062118,0.0001766739,0.000393387,0.0003442834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006876639,0.0001030795,0.003842003,0.0124881,0.0009866642,0.002278627,0.00002608952,0.000004222886,0.000002653978,0.000004047092,0.002744582,0.9774511],"study_design_scores_gemma":[0.001507357,0.0002269197,0.00109366,0.1506937,0.004284637,0.005032537,0.0000121145,0.00001973964,0.000001127359,0.0000326099,0.8368705,0.0002251301],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002530191,0.9950119,0.00004695035,0.000104613,0.0004003628,0.000611037,0.00003177661,0.000008234165,0.001254892],"genre_scores_gemma":[0.0002616008,0.9944078,0.0003088347,0.0001778649,0.001888124,0.0001603479,0.000008688512,0.00007658642,0.002710172],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.977226,"threshold_uncertainty_score":0.9999634,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020684281","doi":"10.1038/bjc.2011.100","title":"Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":473,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Pfizer Australia; Pfizer","keywords":"Medicine; Internal medicine; Colorectal cancer; Oncology; Chemotherapy; Neutrophil to lymphocyte ratio; Cohort; Biomarker; Progression-free survival; Cancer; Lymphocyte","retraction":null,"screen_n_in":null,"score":{"opus":0.007573937637656779,"gpt":0.2432895571130003,"spread":0.2357156194753435,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001276977,0.0001753251,0.0004847908,0.0001358357,0.000047399,0.00002289219,0.0001451867,0.00008335747,0.0005971843],"category_scores_gemma":[0.00004027139,0.0001578417,0.0001245649,0.0001924997,0.0001185153,0.000301204,0.0000185052,0.0002241168,0.000001487973],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004785198,"about_ca_system_score_gemma":0.0006029963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002308972,"about_ca_topic_score_gemma":0.0004338377,"domain_scores_codex":[0.9984521,0.00004318457,0.0005187624,0.0001844858,0.0005113129,0.0002901895],"domain_scores_gemma":[0.9987638,0.00001729911,0.000408581,0.0001047375,0.0004974941,0.0002080963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006614403,0.0003814798,0.8915156,0.00005252124,0.0003602569,0.0004195912,0.0002222565,0.0000151476,0.0001587162,0.000001541746,0.0002763575,0.0999822],"study_design_scores_gemma":[0.01578002,0.0005676052,0.9777685,0.001118323,0.0001437802,0.00008385695,0.0000291779,0.00001193638,0.003751138,0.00001247598,0.0005632274,0.0001699264],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941602,0.004374621,0.000008997989,0.0001279077,0.0004348522,0.0004933993,0.00004689025,0.00001830038,0.0003347822],"genre_scores_gemma":[0.9958661,0.002371893,0.0008184795,0.000607681,0.0001455653,0.00008417016,0.000003524849,0.00004601809,0.00005663573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09981228,"threshold_uncertainty_score":0.6538749,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055557358","doi":"10.1038/bjc.2013.725","title":"Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":470,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"Cancer Care Ontario","keywords":"Observational study; Population; Medicine; Randomized controlled trial; MEDLINE; Family medicine; Internal medicine; Biology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.8739839157445691,"gpt":0.6345413603989247,"spread":0.2394425553456444,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.623098,0.00008318509,0.003564456,0.0003233606,0.00009117792,0.0004177735,0.0009832326,0.00007190626,0.002771408],"category_scores_gemma":[0.589415,0.00003746305,0.001036845,0.0008171982,0.00009983864,0.000242569,0.00002063165,0.0002641835,0.000004062933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006951963,"about_ca_system_score_gemma":0.000614916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008812773,"about_ca_topic_score_gemma":0.001620867,"domain_scores_codex":[0.9075231,0.06512936,0.01234638,0.0002659403,0.01456588,0.0001693487],"domain_scores_gemma":[0.8673835,0.1194207,0.008897809,0.0005521881,0.003597252,0.0001485554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004512303,0.0001890478,0.6683715,0.0001605279,0.0006249713,0.00003907395,0.0005516363,0.004877645,0.0001533069,0.007975263,0.07763956,0.2349052],"study_design_scores_gemma":[0.03185213,0.00009868832,0.8877156,0.002277976,0.0003620339,0.00007261625,0.0005733891,0.04939173,0.000005269613,0.02077916,0.006765167,0.0001062377],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9304902,0.04098601,0.01178146,0.01495619,0.0002773286,0.001214949,0.00000660273,6.496384e-7,0.0002866136],"genre_scores_gemma":[0.9983904,0.0006430674,0.0003270128,0.0002546047,0.0002270462,0.0000459151,5.81521e-7,0.000002773536,0.0001086338],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2347989,"threshold_uncertainty_score":0.9981402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002783201","doi":"10.1038/bjc.2012.366","title":"Projections of cancer prevalence in the United Kingdom, 2010–2040","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":448,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Institute for Health and Care Research; King's College London; Macmillan Cancer Support","keywords":"Medicine; Demography; Cancer registry; Cancer; Incidence (geometry); Population; Cancer incidence; Prostate cancer; Projections of population growth; Colorectal cancer; Quarter (Canadian coin); Lung cancer; Gerontology; Relative survival; Environmental health; Geography; Population growth; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.049573930463883,"gpt":0.3510223883193181,"spread":0.3014484578554351,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005435785,0.00008508758,0.0002510191,0.0001665206,0.00004704389,0.00001934559,0.0001566233,0.00006341892,0.0006673546],"category_scores_gemma":[0.00007980689,0.00006966371,0.0001269869,0.0005910899,0.0000861636,0.0001848523,0.00001588204,0.000434217,0.000001223691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001525639,"about_ca_system_score_gemma":0.0003245233,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05211306,"about_ca_topic_score_gemma":0.03225452,"domain_scores_codex":[0.998747,0.00009951607,0.000396134,0.00007798748,0.0004409417,0.0002384447],"domain_scores_gemma":[0.999075,0.0000603706,0.0002835375,0.0001226678,0.0003651953,0.00009325819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003574728,0.0003290335,0.9300992,0.00049079,0.0001570731,0.00009225319,0.003239038,0.00007175676,0.0008588394,0.00009046301,0.01067135,0.05354271],"study_design_scores_gemma":[0.001208996,0.0001204661,0.8747004,0.002621325,0.0002613906,0.0009203315,0.0007382343,0.000009943958,0.0008477592,0.00002010224,0.1184461,0.0001049719],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9527225,0.04374512,0.00002700505,0.0009952034,0.001537296,0.0002043558,0.00003503755,0.000005327659,0.0007281161],"genre_scores_gemma":[0.9879209,0.009715784,0.00003569671,0.0006238315,0.0009738043,0.00004063446,0.000001572172,0.00001409716,0.0006736114],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1077748,"threshold_uncertainty_score":0.9854043,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2735904407","doi":"10.1038/bjc.2017.220","title":"HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer","year":2017,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immune system; Tumor microenvironment; Immune checkpoint; CD8; Cancer; Immunology; Immunotherapy; Cancer research; Cancer cell; Medicine; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07567563179933269,"gpt":0.3982586436174249,"spread":0.3225830118180922,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001021811,0.0002968175,0.002232476,0.0001731072,0.0001102698,0.0001088953,0.0005697033,0.0002397127,0.0005372389],"category_scores_gemma":[0.0002775925,0.0001932818,0.0008029605,0.0003195065,0.0002472434,0.0001475214,0.00005148481,0.001031183,0.000001354009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000387333,"about_ca_system_score_gemma":0.00394687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005237087,"about_ca_topic_score_gemma":0.002540935,"domain_scores_codex":[0.9970319,0.0001965544,0.001728299,0.0002011142,0.0005256651,0.0003165263],"domain_scores_gemma":[0.9961484,0.0002625659,0.002859046,0.0003350695,0.0003109665,0.00008394772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000371718,0.00008450526,0.000169921,0.007801884,0.0008008215,0.0005310409,0.00009111709,0.000004440296,0.00007090719,9.314536e-7,0.001339972,0.9887328],"study_design_scores_gemma":[0.001519535,0.0002456489,0.001959309,0.1757278,0.001387701,0.002875609,0.00004685636,0.000001816517,0.00006385074,0.000003210413,0.8159751,0.0001935446],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001465809,0.9955767,0.0000017417,0.0002144909,0.001419047,0.0008920622,0.0001221672,0.000004504144,0.0003034502],"genre_scores_gemma":[0.0008180644,0.9968607,0.00007854019,0.0001252764,0.0009182915,0.00009488565,0.00000430718,0.00006207835,0.001037841],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9885392,"threshold_uncertainty_score":0.7916944,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015943054","doi":"10.1038/bjc.2014.418","title":"Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pancreatic cancer; Malignancy; BRCA mutation; Internal medicine; Oncology; Adenocarcinoma; Stage (stratigraphy); Cancer; Pancreatic ductal adenocarcinoma; Gastroenterology; Breast cancer; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0290428155288431,"gpt":0.3876839837172945,"spread":0.3586411681884514,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001121387,0.00007162266,0.0007558339,0.00008318948,0.00002461473,0.00001266059,0.00005929377,0.0001038507,0.0002440558],"category_scores_gemma":[0.0008125814,0.00007067333,0.00007926858,0.00008159333,0.0001880963,0.00007075046,0.00001657081,0.0003598266,5.305282e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001062551,"about_ca_system_score_gemma":0.0005324259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002298926,"about_ca_topic_score_gemma":0.001669192,"domain_scores_codex":[0.9984833,0.0001933856,0.0007348832,0.0001066431,0.0003096822,0.0001720898],"domain_scores_gemma":[0.9987516,0.0003138386,0.0003639568,0.00006781009,0.0003311532,0.0001716702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003984498,0.00007007181,0.8386984,0.0001115293,0.0001560799,0.0001822144,0.00008778176,0.000002731258,0.0001406397,0.00002637764,0.0001614826,0.1599643],"study_design_scores_gemma":[0.003790231,0.0004447687,0.9921237,0.001116312,0.0002904332,0.0003587357,0.00007241303,0.0006092584,0.00002767339,0.0001142331,0.0009908916,0.00006135678],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946891,0.003694156,0.0001123567,0.000431429,0.0002985384,0.0001245968,0.00002530154,0.000002333098,0.0006221654],"genre_scores_gemma":[0.9792157,0.01967711,0.0002817793,0.0001367237,0.000437235,0.000005863642,0.000002165839,0.00001135805,0.0002320384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1599029,"threshold_uncertainty_score":0.3475304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132378346","doi":"10.1038/sj.bjc.6601839","title":"Role of osteopontin in tumour progression","year":2004,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":412,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Osteopontin; Metastasis; Cancer; Biology; Cancer research; Malignant transformation; Tumor progression; Pathology; Medicine; Bioinformatics; Immunology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02087472759048995,"gpt":0.3671525670849019,"spread":0.3462778394944119,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002582113,0.0001557495,0.001796829,0.0001590201,0.00002005072,0.00001365979,0.0001003072,0.0001452656,0.00007945313],"category_scores_gemma":[0.00008595143,0.0001319723,0.0003946684,0.0002637311,0.00006086477,0.00006507114,0.00004890135,0.0005839903,0.000003204245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001997948,"about_ca_system_score_gemma":0.0007776804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000410547,"about_ca_topic_score_gemma":0.0003279389,"domain_scores_codex":[0.9983109,0.00005086532,0.0009632725,0.0001172385,0.0003949734,0.0001627441],"domain_scores_gemma":[0.9986849,0.00002044631,0.000919477,0.00006967466,0.0002286842,0.00007681138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004090262,0.0001107475,0.0001175715,0.01140027,0.000115837,0.001015623,0.00002784937,2.300222e-7,0.00001113834,0.000001994419,0.0003015989,0.9868562],"study_design_scores_gemma":[0.001086307,0.0002119359,0.001049571,0.379301,0.0005546424,0.00581846,0.00005538744,4.876696e-8,0.00005443813,0.00005881788,0.6116977,0.000111755],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000584522,0.9979628,6.338564e-7,0.0000266071,0.0001614117,0.0004278902,0.0000160065,0.000003454147,0.0008166867],"genre_scores_gemma":[0.001010656,0.9981763,0.0002121797,0.00001624237,0.0003400557,0.00002678104,0.000002736072,0.0000279364,0.0001871645],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9867445,"threshold_uncertainty_score":0.5381674,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2084330540","doi":"10.1038/sj.bjc.6601676","title":"Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Hazard ratio; Fluorouracil; Regimen; Confidence interval; Gastroenterology; Population; Proportional hazards model; Colorectal cancer; Oncology; Surgery; Chemotherapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1004104825505594,"gpt":0.4197499322979251,"spread":0.3193394497473658,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007506731,0.0002165988,0.001461687,0.0000924992,0.0001537573,0.0001218333,0.0001272964,0.00005823388,0.0002477088],"category_scores_gemma":[0.0006953559,0.0001701881,0.0001370593,0.0001704989,0.0001190388,0.0002517171,0.00009435774,0.0002968302,4.981794e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000185917,"about_ca_system_score_gemma":0.0003959446,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009698042,"about_ca_topic_score_gemma":0.007844936,"domain_scores_codex":[0.9981767,0.00007976372,0.0008559845,0.0003011774,0.0003317113,0.000254643],"domain_scores_gemma":[0.9985673,0.0002420102,0.0004584786,0.0001742399,0.0003204479,0.0002374948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.06280386,0.001612749,0.001850243,0.00004264151,0.005911595,0.002266887,0.0008056047,0.00004799058,0.007300331,0.00001071946,0.001603628,0.9157438],"study_design_scores_gemma":[0.8974772,0.002725196,0.04477843,0.002136899,0.007309041,0.004070607,0.001122653,0.0001999845,0.003018076,0.0001849846,0.03647838,0.0004985289],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8904876,0.1053335,0.001553436,0.0007246131,0.0002899813,0.0004141874,0.001101929,0.00001241575,0.00008239916],"genre_scores_gemma":[0.96434,0.0329404,0.001471982,0.0002555299,0.0007710001,0.00001190092,0.00009726555,0.0000221341,0.00008980287],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9152452,"threshold_uncertainty_score":0.9968964,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159334966","doi":"10.1038/sj.bjc.6601856","title":"Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Doxorubicin; Pharmacology; Toxicity; Medicine; Maximum tolerated dose; Poloxamer; Chemotherapy; Internal medicine; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.008120481377496757,"gpt":0.304287108893021,"spread":0.2961666275155243,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001245025,0.0001118555,0.0003710694,0.0001248919,0.00003515984,0.0000188143,0.00004989323,0.00004577866,0.00005143342],"category_scores_gemma":[0.00001293236,0.0001104085,0.00004673165,0.0002327574,0.00005601703,0.0002250156,0.000008903289,0.0002489664,1.103023e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002660011,"about_ca_system_score_gemma":0.00024422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00110543,"about_ca_topic_score_gemma":0.001549632,"domain_scores_codex":[0.9988126,0.00003408948,0.0004212297,0.0001443904,0.0004327511,0.0001550062],"domain_scores_gemma":[0.9992579,0.00001397638,0.0003227835,0.00006898465,0.0002352948,0.0001010442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004699405,0.003957846,0.07952529,0.0001239386,0.0003579878,0.0001467093,0.001670046,0.001909872,0.1526463,0.000002598063,0.0000186186,0.7549413],"study_design_scores_gemma":[0.1197596,0.004662715,0.7007431,0.002138196,0.00034749,0.0001399269,0.0003720655,0.00001734066,0.1714914,0.00002682232,0.0001209291,0.0001804293],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909348,0.008193352,0.0000253692,0.0001445046,0.0001204584,0.0005267118,0.00001439243,0.000004951202,0.00003543474],"genre_scores_gemma":[0.9976441,0.001958292,0.0000421627,0.000166303,0.000128514,0.00001632126,0.000003202802,0.00002093434,0.00002020606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7547609,"threshold_uncertainty_score":0.4502329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3138474425","doi":"10.1038/s41416-021-01321-0","title":"Achieving clinical success with BET inhibitors as anti-cancer agents","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":354,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Cancer; Oncology; Bioinformatics; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04076842658982904,"gpt":0.4049207177462221,"spread":0.364152291156393,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005157742,0.000314024,0.001359284,0.0000803507,0.00009809661,0.0001795076,0.0004236014,0.0004485886,0.0003351418],"category_scores_gemma":[0.0001871447,0.000284654,0.0007865796,0.0002130809,0.0001269983,0.00001889829,0.0001373311,0.000730964,0.00000407052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006762819,"about_ca_system_score_gemma":0.001658113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000101075,"about_ca_topic_score_gemma":0.0001437603,"domain_scores_codex":[0.9973251,0.0003303342,0.001212726,0.0004176558,0.0004329883,0.0002811926],"domain_scores_gemma":[0.9976456,0.00002048815,0.001418516,0.0002319295,0.0004548126,0.000228609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001759401,0.00007243109,0.001133214,0.0008906561,0.0006854127,0.0002402478,0.000002749938,0.000005991652,0.0000257841,0.000001317591,0.01937806,0.9775465],"study_design_scores_gemma":[0.0005726383,0.0001749362,0.0001840513,0.02425628,0.0004774469,0.001009446,0.000008386013,1.552542e-7,0.000561782,4.372411e-7,0.9724075,0.0003469908],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01702309,0.980962,0.000027551,0.00006055571,0.001372835,0.000246333,0.00009683806,0.00000470268,0.0002060729],"genre_scores_gemma":[0.0006717519,0.993932,0.0001161686,0.0002808993,0.003796455,0.00003777686,0.00009042015,0.00007512017,0.0009994267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9771996,"threshold_uncertainty_score":0.9999605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093082116","doi":"10.1038/sj.bjc.6600799","title":"Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Embarrassment; Health professionals; Health care; Perspective (graphical); Medicine; Reproductive health; Affect (linguistics); Quarter (Canadian coin); Gynecology; Family medicine; Nursing; Psychology; Social psychology; Population","retraction":null,"screen_n_in":null,"score":{"opus":0.03709343774743502,"gpt":0.3785108125350339,"spread":0.3414173747875989,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004500762,0.00009785168,0.0004607857,0.00006164228,0.00007814601,0.00002319313,0.00008940289,0.00007953467,0.0003265551],"category_scores_gemma":[0.00003542973,0.00008872164,0.00002965337,0.0001648761,0.0001091013,0.0001303324,0.00001758759,0.0003364229,2.485644e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000170764,"about_ca_system_score_gemma":0.0006660838,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009355249,"about_ca_topic_score_gemma":0.01510012,"domain_scores_codex":[0.9987444,0.0001519873,0.0004057021,0.0001139425,0.0003892728,0.0001946867],"domain_scores_gemma":[0.998602,0.00004644898,0.0003877195,0.0001443169,0.0006209058,0.0001985986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007041797,0.0001146088,0.7050427,0.0007753812,0.0004498588,0.00006778757,0.006645313,0.000008473085,0.000219033,0.000150543,0.002978049,0.2828441],"study_design_scores_gemma":[0.003204215,0.0006914938,0.9026424,0.005637119,0.0001762148,0.0004980615,0.006286933,0.000001097483,0.001129952,0.0002444301,0.07929305,0.000195078],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8912661,0.1043447,0.00001387883,0.003743176,0.0001294997,0.0001644233,0.00007677148,0.000005672929,0.0002558255],"genre_scores_gemma":[0.9850016,0.01290136,0.0002410572,0.0006916641,0.0002468483,0.00003072388,0.000004307965,0.00002132348,0.0008610885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.282649,"threshold_uncertainty_score":0.9972416,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005410969","doi":"10.1038/sj.bjc.6600609","title":"Choroid plexus tumours","year":2002,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Choroid plexus papilloma; Choroid plexus; Medicine; Papilloma; Choroid; Radiation therapy; Pathology; Carcinoma; Radiology; Internal medicine; Central nervous system; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04784246737132741,"gpt":0.3570897696475382,"spread":0.3092473022762108,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001377484,0.0002548739,0.002036251,0.0001846366,0.00004777509,0.00007116569,0.0001466075,0.0001749839,0.001848079],"category_scores_gemma":[0.00005964224,0.000218012,0.001061833,0.0002051537,0.00004099825,0.00006485169,0.00002118119,0.0005707716,0.00004789871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004062574,"about_ca_system_score_gemma":0.0004000696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001496846,"about_ca_topic_score_gemma":0.00007762112,"domain_scores_codex":[0.998231,0.0000565339,0.000813817,0.0001790791,0.0004627805,0.0002567752],"domain_scores_gemma":[0.9984849,0.00005456688,0.0008043155,0.0001446537,0.0002284057,0.0002831397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005221521,0.0002245653,0.0001104994,0.002416685,0.000582341,0.009591657,0.000005418931,3.91556e-7,1.123412e-7,0.00000254565,0.03811232,0.9489483],"study_design_scores_gemma":[0.001030662,0.0001561443,0.0005428779,0.07339193,0.003798952,0.03857123,0.000003112437,2.089062e-7,0.000001987476,0.000005041371,0.8823468,0.0001510628],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001299482,0.9974191,6.114314e-7,0.0000992379,0.0006669884,0.0003214039,0.00007764228,0.000008925746,0.001276148],"genre_scores_gemma":[0.0001043298,0.9973192,0.0001039705,0.0001099497,0.001538145,0.00004768825,0.00001132422,0.00006269918,0.0007026643],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9487972,"threshold_uncertainty_score":0.9990644,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2022540212","doi":"10.1038/sj.bjc.6601314","title":"Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"University of Toronto","keywords":"Relative risk; Medicine; Breast cancer; Confidence interval; Cohort study; Cohort; Meta-analysis; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04609238137663645,"gpt":0.3448777737755354,"spread":0.2987853923988989,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005091396,0.0003233233,0.005091279,0.0002688922,0.0001308683,0.0001395196,0.0002172428,0.0002198794,0.001416076],"category_scores_gemma":[0.00013294,0.0001915195,0.004995883,0.001627492,0.0001282058,0.0001563465,0.00007470301,0.001027158,2.471129e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001427793,"about_ca_system_score_gemma":0.0002650922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007412771,"about_ca_topic_score_gemma":0.0005325493,"domain_scores_codex":[0.9973053,0.0002912528,0.001184128,0.0002954544,0.0007050652,0.0002188113],"domain_scores_gemma":[0.9964217,0.0001255064,0.001885469,0.0002586916,0.001136435,0.0001722321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005777684,0.0001268321,0.0008307138,0.008663773,0.3299282,0.0002182431,0.00002226598,0.000003225083,1.942636e-7,0.000008513683,0.06902188,0.5911184],"study_design_scores_gemma":[0.0002949579,0.00002318986,0.00323065,0.01021079,0.4087415,0.001572298,0.000006507738,2.893076e-7,7.500291e-8,0.00002535541,0.5757842,0.0001101346],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000322128,0.9918907,8.351363e-7,0.000839621,0.0002333016,0.0003434227,0.006442271,0.000002874177,0.0002147831],"genre_scores_gemma":[0.00005984585,0.9979863,0.00008647017,0.0005392176,0.0006072706,0.000047765,0.0000387056,0.00003097644,0.0006034231],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5910082,"threshold_uncertainty_score":0.9994968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070855246","doi":"10.1038/sj.bjc.6602304","title":"Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Term (time); Cancer; Surgery; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.009585676431239868,"gpt":0.2872650697998153,"spread":0.2776793933685754,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003144629,0.0001766525,0.0006229111,0.0001400448,0.00004753626,0.00001929849,0.0001303263,0.00008376248,0.004366047],"category_scores_gemma":[0.00001413535,0.0001549749,0.0002078818,0.0002490058,0.0001177579,0.0002225006,0.0000180239,0.0003112911,0.000003090938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003295492,"about_ca_system_score_gemma":0.0006296522,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004736585,"about_ca_topic_score_gemma":0.04824129,"domain_scores_codex":[0.9985206,0.00009017755,0.0004860529,0.0001692936,0.00042458,0.0003093097],"domain_scores_gemma":[0.9984804,0.00006333346,0.0004325951,0.000104643,0.0006803859,0.0002386268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003168123,0.00044735,0.5330929,0.0002456036,0.001338629,0.002916562,0.00023237,0.00009171652,0.002879871,0.000001519566,0.002140964,0.4534444],"study_design_scores_gemma":[0.01049526,0.001202782,0.9555275,0.002231612,0.0008678388,0.02438994,0.00005451183,0.000008028012,0.001243909,0.000002177419,0.003786749,0.000189648],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9631962,0.03318417,0.00003176426,0.002453101,0.0005139537,0.0002376309,0.0001749049,0.00001280594,0.0001955296],"genre_scores_gemma":[0.9894319,0.006837374,0.0001050127,0.0008529351,0.000718835,0.00002785071,0.000007675754,0.00004015338,0.00197823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4532547,"threshold_uncertainty_score":0.9965441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010666032","doi":"10.1038/sj.bjc.6603043","title":"Towards third generation matrix metalloproteinase inhibitors for cancer therapy","year":2006,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":336,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Matrix metalloproteinase inhibitor; Matrix metalloproteinase; Cancer; Tissue inhibitor of metalloproteinase; Drug; Pharmacology; Metalloproteinase; Medicine; Clinical trial; Cancer research; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03517154971347457,"gpt":0.3501934623059883,"spread":0.3150219125925137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004209718,0.0003381043,0.0009766028,0.00008998434,0.000111676,0.0001225683,0.0002986387,0.0004702178,0.00005516342],"category_scores_gemma":[0.00004345508,0.0003158695,0.001035648,0.0001067083,0.00003729318,0.00001570294,0.0000429715,0.0002861796,0.000001042213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001121359,"about_ca_system_score_gemma":0.001261552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004902685,"about_ca_topic_score_gemma":0.0004712788,"domain_scores_codex":[0.9980877,0.0001185906,0.000867454,0.0003319315,0.0003032443,0.0002911047],"domain_scores_gemma":[0.9982359,0.000006104177,0.001024242,0.0001744479,0.0004473526,0.0001119683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003334612,0.00004906788,2.516538e-7,0.000892168,0.0003688388,0.00003921489,0.000002201572,0.00001224097,0.01084194,0.000009174093,0.03642166,0.9513299],"study_design_scores_gemma":[0.0006446055,0.0002744313,2.665341e-7,0.003483171,0.0003920329,0.0003613874,0.00000147922,0.000002645173,0.05989591,0.00004921818,0.9345505,0.0003443054],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004101744,0.9955686,0.001012733,0.00003924529,0.00149279,0.0009715996,0.0004390946,0.000005877322,0.00005989653],"genre_scores_gemma":[0.00006344222,0.986775,0.001016517,0.000119019,0.009985461,0.0005889937,0.0001943364,0.00008824222,0.001168958],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9509856,"threshold_uncertainty_score":0.9999293,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168362647","doi":"10.1038/sj.bjc.6605736","title":"BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":325,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Cancer Council Victoria; National Health and Medical Research Council; Cancer Research UK","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Hazard ratio; Univariate analysis; Proportional hazards model; Lymph node; Confidence interval; Stage (stratigraphy); Progesterone receptor; Multivariate analysis; Cancer; Prognostic variable; Estrogen receptor; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.005290732897433089,"gpt":0.2664471361402568,"spread":0.2611564032428237,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000218843,0.0001445955,0.0003183447,0.00003699086,0.00004966991,0.00003221916,0.0001482588,0.0001135348,0.00006381387],"category_scores_gemma":[0.00003582348,0.0001413523,0.00008657108,0.00009182572,0.0001463932,0.00001718527,0.00005978052,0.0002351126,1.956292e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003195392,"about_ca_system_score_gemma":0.0002043056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002588716,"about_ca_topic_score_gemma":0.006363229,"domain_scores_codex":[0.9989481,0.00004862182,0.0003353533,0.0002094451,0.0002067327,0.0002517547],"domain_scores_gemma":[0.9992012,0.00001511599,0.0002785105,0.0001124833,0.0003113902,0.00008130897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007832717,0.0001708643,0.6053178,0.00003349638,0.0003362775,0.0001325192,0.0001458915,0.00007212274,0.2292519,0.000002405899,0.0002497338,0.1635038],"study_design_scores_gemma":[0.002880518,0.00009888106,0.9550871,0.0002975792,0.00003772341,0.00106675,0.0001191481,0.000004931973,0.03778639,0.00004388232,0.00241868,0.0001584269],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.949582,0.04921063,0.000008116863,0.0005783566,0.0002594219,0.0001400274,0.0001778957,0.000002221944,0.00004128763],"genre_scores_gemma":[0.96193,0.03754906,0.0001207539,0.0001466567,0.0001550752,0.00003791397,0.00000416249,0.00002237435,0.00003400798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3497693,"threshold_uncertainty_score":0.5764178,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017082986","doi":"10.1038/sj.bjc.6603419","title":"A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Temsirolimus; Medicine; Pharmacodynamics; Rash; Internal medicine; Sirolimus; Everolimus; Adverse effect; Oncology; Pharmacology; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Biology; Pharmacokinetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02542672549639566,"gpt":0.4100298367940532,"spread":0.3846031112976576,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002209364,0.0001412423,0.0007195438,0.0002534055,0.00004668181,0.00001546741,0.0001405678,0.000006174901,0.00005469594],"category_scores_gemma":[0.0002008323,0.0001461101,0.0001089716,0.0002975714,0.0001649056,0.0002254577,0.00008772993,0.0006752887,2.790644e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000049806,"about_ca_system_score_gemma":0.000178428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001391107,"about_ca_topic_score_gemma":0.002726883,"domain_scores_codex":[0.997533,0.0001704838,0.001163791,0.0002450795,0.0005457942,0.0003418884],"domain_scores_gemma":[0.9988829,0.0001074121,0.0004080173,0.0001292362,0.0002684082,0.0002040237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00478139,0.01220163,0.5985174,0.0001811056,0.0001088099,0.1072108,0.00004397093,0.0002594644,0.01529796,0.000005050479,0.0006610373,0.2607314],"study_design_scores_gemma":[0.1076803,0.01993638,0.8179324,0.0006809371,0.000227643,0.04192047,0.00031616,0.0003731495,0.002938264,0.00009863453,0.007672654,0.0002230837],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879664,0.01066317,0.000001776021,0.0003395648,0.0002356169,0.0005761837,0.00001616748,0.000009166039,0.0001919676],"genre_scores_gemma":[0.9944215,0.004653357,0.0001105269,0.00009505322,0.0002999403,0.00001813572,0.000001070492,0.00002979692,0.0003706284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2605083,"threshold_uncertainty_score":0.5958198,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971081363","doi":"10.1038/sj.bjc.6603924","title":"FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":293,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Prostate Cancer Research Initiative; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"PTEN; Prostate cancer; Biology; Prostate; Fluorescence in situ hybridization; Cancer research; Tissue microarray; Oncology; Pathology; Internal medicine; Medicine; Cancer; Gene; Genetics; Chromosome; PI3K/AKT/mTOR pathway","retraction":null,"screen_n_in":null,"score":{"opus":0.05772958306902826,"gpt":0.3916746011988517,"spread":0.3339450181298234,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001512005,0.000151428,0.0009518309,0.0003596366,0.00007159926,0.00003877561,0.0001402531,0.0001320984,0.0005808623],"category_scores_gemma":[0.0001165305,0.0001251597,0.0004621565,0.000731197,0.0002069922,0.0001494141,0.0000251137,0.0004883833,0.000001044914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009795842,"about_ca_system_score_gemma":0.0007094051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001817428,"about_ca_topic_score_gemma":0.01268192,"domain_scores_codex":[0.9974937,0.00007684508,0.0009743827,0.0002256448,0.0008168223,0.000412539],"domain_scores_gemma":[0.99771,0.0001330016,0.0008497431,0.0001333296,0.0008705046,0.0003033816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002448195,0.0001749469,0.9143792,0.00004193765,0.00646605,0.001245917,0.0001973832,0.00009809943,0.0004390947,4.976055e-7,0.002790783,0.07171792],"study_design_scores_gemma":[0.006076936,0.0006882277,0.9830193,0.0006000194,0.003659898,0.0001839999,0.0001945819,0.0001530606,0.001654172,0.000005746349,0.003615402,0.0001486661],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920834,0.005635003,0.0001012903,0.001020212,0.0002017857,0.0003070573,0.0002754846,0.00001070135,0.0003650416],"genre_scores_gemma":[0.9882686,0.008156177,0.0001558718,0.001074744,0.0002067827,0.000008025587,0.0000406202,0.00002965364,0.002059571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07156925,"threshold_uncertainty_score":0.7076807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078978161","doi":"10.1038/sj.bjc.6600537","title":"The association of breast mitogens with mammographic densities","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation; Health Sciences Centre; Sunnybrook Health Science Centre; Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Prolactin; Internal medicine; Endocrinology; Sex hormone-binding globulin; Hormone; Risk factors for breast cancer; Anthropometry; Risk factor; Globulin; Mammography; MAMMOGRAPHIC DENSITY; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.005265437800796183,"gpt":0.2095724450219589,"spread":0.2043070072211627,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000177636,0.00005571082,0.0001805854,0.00008040736,0.00006804484,0.00006395946,0.00005965662,0.00002555109,0.00004071067],"category_scores_gemma":[0.00002683283,0.00004091504,0.0001585826,0.0002549653,0.00009269053,0.0001602961,0.000005146713,0.0001554733,5.340406e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004419027,"about_ca_system_score_gemma":0.00003833845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008499259,"about_ca_topic_score_gemma":0.0002623932,"domain_scores_codex":[0.9991488,0.00002067794,0.0002353612,0.00004899219,0.0004021965,0.0001439893],"domain_scores_gemma":[0.9990236,0.0000567295,0.000320632,0.00005239373,0.0004794403,0.00006720165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001786948,0.0001279211,0.5657185,0.00003961922,0.0006738198,0.0003047547,0.0001027301,0.000008397512,0.0002672624,0.00002851471,0.006566297,0.4259835],"study_design_scores_gemma":[0.001817604,0.0002088449,0.958246,0.0013312,0.000343961,0.02415748,0.0002914943,0.00001886032,0.0003336832,0.00008211986,0.01307738,0.00009136137],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9745568,0.01982029,0.00001989557,0.001864898,0.0001567412,0.00005855763,0.00002946866,0.000006771865,0.003486596],"genre_scores_gemma":[0.9946004,0.004322155,0.00007350315,0.0001181644,0.0002320387,0.000001507851,4.087292e-7,0.000009211919,0.0006425799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4258921,"threshold_uncertainty_score":0.1668467,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076952890","doi":"10.1038/bjc.2012.524","title":"Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":269,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital; University of British Columbia; University of Victoria; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Office of Defense Programs; BC Cancer Foundation; Natural Sciences and Engineering Research Council of Canada; U.S. Department of Defense","keywords":"FOXP3; Breast cancer; Tumor-infiltrating lymphocytes; Immune system; Cytotoxic T cell; CD8; Medicine; Cancer research; Oncology; Cancer; Internal medicine; IL-2 receptor; Immunology; Biology; T cell; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.02303251073241613,"gpt":0.2943119832179169,"spread":0.2712794724855007,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001147052,0.0002479847,0.0008762137,0.0001332146,0.0002008134,0.00004367685,0.0002396236,0.0003673184,0.0005055524],"category_scores_gemma":[0.0004490106,0.0002238919,0.0001594049,0.000213184,0.0005045329,0.0003598164,0.00007604655,0.0009417579,0.00001299791],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002967032,"about_ca_system_score_gemma":0.0003731262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002079577,"about_ca_topic_score_gemma":0.002419208,"domain_scores_codex":[0.9970605,0.000859875,0.001117576,0.0002365795,0.00009166449,0.000633819],"domain_scores_gemma":[0.9976455,0.0006669022,0.001214779,0.0001128678,0.0002809281,0.00007905297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001199149,0.0003020275,0.747224,0.00001219852,0.0005754761,0.00007688717,0.0002085965,0.000004011401,0.2377078,0.000006799684,0.0002662407,0.01241683],"study_design_scores_gemma":[0.006539115,0.0002971515,0.9290809,0.001112912,0.0001474599,0.003600272,0.0007229968,6.68369e-7,0.05724876,0.00001561589,0.0009311446,0.0003030186],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9365991,0.06162129,0.000003152485,0.0003778488,0.000903791,0.0001626198,0.0002395935,0.00001984792,0.00007270669],"genre_scores_gemma":[0.9931272,0.005687669,0.00007805521,0.000194918,0.0002121592,0.00002694322,0.000008659706,0.00003440025,0.0006299779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1818569,"threshold_uncertainty_score":0.9130049,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076908467","doi":"10.1038/bjc.2013.187","title":"Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":268,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Brock University; McMaster University; Juravinski Cancer Centre","funders":"Canadian Institutes of Health Research; University of Toronto; Institut National de la Santé et de la Recherche Médicale; McMaster University","keywords":"Metformin; AMPK; Lung cancer; Medicine; Oncology; Internal medicine; Cell growth; Cancer research; non-small cell lung cancer (NSCLC); Biology; Kinase; Protein kinase A; A549 cell; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.005009198573266756,"gpt":0.2446573350131916,"spread":0.2396481364399248,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002803905,0.0001320397,0.0002937419,0.00003992794,0.00005717017,0.00005704775,0.0001089568,0.0001161473,0.00008356359],"category_scores_gemma":[0.00006557698,0.0001341901,0.00007508846,0.00008076447,0.0001008047,0.00004629349,0.00004326172,0.0001187781,2.868154e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001931799,"about_ca_system_score_gemma":0.0002459289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001094758,"about_ca_topic_score_gemma":0.0002989128,"domain_scores_codex":[0.99897,0.00008618044,0.0003818292,0.0001905109,0.0001653873,0.0002060451],"domain_scores_gemma":[0.9990984,0.00002770436,0.0004012829,0.00008344648,0.0002849248,0.0001041969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003225728,0.00004178662,0.00672019,0.000204796,0.0001425407,0.000006308233,0.0003554166,0.00001588935,0.6470851,0.000004211603,0.004389137,0.3407121],"study_design_scores_gemma":[0.001646598,0.0001835194,0.0319136,0.000335864,0.0001120576,0.00006175563,0.0001140934,0.00002034469,0.9423185,0.00006823755,0.02302145,0.0002039819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5621943,0.4372974,0.0001226564,0.00002820267,0.0001582464,0.00009995467,0.00002492555,0.000001047445,0.00007329416],"genre_scores_gemma":[0.6075633,0.3913786,0.000393578,0.0002132623,0.0003088149,0.00002523002,0.000002200006,0.00001344084,0.0001015551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3405081,"threshold_uncertainty_score":0.5472112,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116372322","doi":"10.1038/sj.bjc.6602121","title":"Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Genetics","keywords":"Multiplex ligation-dependent probe amplification; Familial adenomatous polyposis; Colorectal cancer; Proband; Gene duplication; Mutation; Adenomatous polyposis coli; Cancer; Germline mutation; Genetics; Mutation testing; Medicine; Point mutation; Multiplex; Biology; Gene; Exon","retraction":null,"screen_n_in":null,"score":{"opus":0.01237002274091054,"gpt":0.3013767852610982,"spread":0.2890067625201876,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000221517,0.0001331038,0.0004842086,0.0002288795,0.00005950318,0.00003617881,0.0001377827,0.000112659,0.0005216077],"category_scores_gemma":[0.00006468973,0.0001414936,0.0002536485,0.0005992787,0.00008698158,0.0001452679,0.00001836436,0.0002165697,0.000001038017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000601383,"about_ca_system_score_gemma":0.0004546028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004347995,"about_ca_topic_score_gemma":0.004879561,"domain_scores_codex":[0.9981303,0.00003721522,0.0007240664,0.0002095589,0.0007087231,0.0001901321],"domain_scores_gemma":[0.9981229,0.00002930125,0.0007158266,0.0001495887,0.0008331689,0.0001491756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0006094131,0.0004634876,0.1543937,0.0002051048,0.00314009,0.00005472215,0.0005803066,0.02635394,0.6357671,0.00001237059,0.0009482272,0.1774715],"study_design_scores_gemma":[0.003066961,0.00034469,0.6862066,0.001017921,0.003617067,0.0001499356,0.0001179044,0.0002643418,0.3033532,0.0001225169,0.001526647,0.0002121953],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9580746,0.03623137,0.004044046,0.0005555875,0.0003964521,0.0003417112,0.0002747725,0.00001230108,0.000069137],"genre_scores_gemma":[0.9871566,0.01071284,0.001403076,0.0001641219,0.0002828411,0.00006773617,0.00004304143,0.00002389388,0.0001458713],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5318128,"threshold_uncertainty_score":0.6572897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072532597","doi":"10.1038/sj.bjc.6603048","title":"Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nausea and vomiting management","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Dexamethasone; Medicine; Nausea; Vomiting; Chemotherapy; Internal medicine; Corticosteroid; Anesthesia; Antiemetic; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.01947014707829188,"gpt":0.2639664318638372,"spread":0.2444962847855453,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000378377,0.0001079444,0.0004482522,0.00007654183,0.00003691032,0.00002617488,0.00008009835,0.00005846204,0.00002589763],"category_scores_gemma":[0.0001708229,0.00007842913,0.000196182,0.0002040513,0.00007693976,0.00008981761,0.00001042946,0.0001412076,9.781712e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008239361,"about_ca_system_score_gemma":0.0001294747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006771036,"about_ca_topic_score_gemma":0.0008816022,"domain_scores_codex":[0.9988416,0.00005981377,0.0004260199,0.0001060893,0.0003838096,0.0001826387],"domain_scores_gemma":[0.9983198,0.0002808252,0.000583044,0.0001080473,0.0006636181,0.00004466352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03465996,0.002951478,0.09231895,0.002345787,0.01187176,0.001171101,0.0006676292,0.004626345,0.0885863,0.00006654886,0.03311968,0.7276145],"study_design_scores_gemma":[0.01672515,0.004310192,0.8658424,0.003581576,0.001929349,0.0002315896,0.00004833384,0.0004808768,0.1026189,0.0002678306,0.003667458,0.0002963134],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991312,0.00454854,0.003093763,0.0003455491,0.00005581444,0.0005740947,0.00003137661,0.00000588435,0.00003296035],"genre_scores_gemma":[0.9959901,0.0004288383,0.002520763,0.0003424176,0.0001454157,0.00004314662,0.000002593213,0.00003150703,0.0004952439],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7735234,"threshold_uncertainty_score":0.3198247,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085115464","doi":"10.1038/sj.bjc.6604054","title":"Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"TMPRSS2; Prostate cancer; Fusion gene; Medicine; Prostate; Erg; PCA3; Oncology; Hazard ratio; Internal medicine; Cancer; Cancer research; Disease; Gene; Biology; Genetics; Ophthalmology","retraction":null,"screen_n_in":null,"score":{"opus":0.02394317498831438,"gpt":0.3299856356982167,"spread":0.3060424607099023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008293446,0.0001848866,0.0005343999,0.0001431973,0.0001455722,0.00003252639,0.0001842149,0.0001272657,0.0003658682],"category_scores_gemma":[0.0001413728,0.0001293087,0.000349224,0.0003650846,0.0002171684,0.0002011896,0.00006669531,0.0003788168,4.233018e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004302035,"about_ca_system_score_gemma":0.001660029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001294815,"about_ca_topic_score_gemma":0.001433172,"domain_scores_codex":[0.9975333,0.00006423434,0.0007694254,0.0002457213,0.0008741608,0.0005131849],"domain_scores_gemma":[0.9975805,0.000166825,0.0005998205,0.0001927022,0.001192938,0.0002672712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01294032,0.0003730705,0.3353589,0.001055104,0.0003157942,0.0005582287,0.0006627975,0.0001610846,0.07392371,9.745793e-7,0.03724712,0.5374029],"study_design_scores_gemma":[0.006019597,0.0003028077,0.4502487,0.01538631,0.00035698,0.0003761364,0.0001121044,0.00006553347,0.4970568,0.00005543758,0.02975971,0.0002598597],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8696983,0.1261578,0.0001881606,0.001156084,0.001495616,0.0008263376,0.0004189244,0.000009163767,0.00004966358],"genre_scores_gemma":[0.9229435,0.07389889,0.0002077907,0.0002899705,0.001016601,0.0002453637,0.000009203591,0.00004112695,0.001347494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5371431,"threshold_uncertainty_score":0.5273055,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978311359","doi":"10.1054/bjoc.2001.2061","title":"Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Medicine; Thyroid cancer; Incidence (geometry); Cohort; Cohort effect; Cohort study; Demography; Thyroid; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01428222867019435,"gpt":0.2907149439135352,"spread":0.2764327152433408,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005415131,0.0001898488,0.0006770519,0.0001826137,0.00009536781,0.00007973272,0.000164156,0.00008197255,0.0004049276],"category_scores_gemma":[0.0002075971,0.0002030648,0.00008947118,0.0005068987,0.00008429453,0.0003578608,0.00004486872,0.0005326211,0.000001316929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001537703,"about_ca_system_score_gemma":0.002101529,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9552156,"about_ca_topic_score_gemma":0.9610367,"domain_scores_codex":[0.9978558,0.00009962959,0.0005746267,0.0002538551,0.0007596959,0.0004563806],"domain_scores_gemma":[0.9989165,0.00008597077,0.0002945513,0.0001207365,0.0002231906,0.0003590532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003614173,0.00001556877,0.700959,0.00003929084,0.00007647906,0.01404103,0.00008123233,0.0001028114,0.001817772,8.225471e-7,0.002600575,0.2799039],"study_design_scores_gemma":[0.001804153,0.0001538096,0.9679803,0.003833391,0.0001582883,0.0206626,0.0000736956,0.0001365671,0.0002784712,0.00001508471,0.004693107,0.0002104934],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9261972,0.07128491,0.00000647052,0.0008751662,0.000278804,0.0001219573,0.00001378063,0.000008304735,0.001213467],"genre_scores_gemma":[0.9865445,0.01061048,0.0002425203,0.00151779,0.0005382713,0.00001858694,0.000002588625,0.00002483872,0.0005003806],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2796935,"threshold_uncertainty_score":0.8280743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035801850","doi":"10.1038/bjc.2012.483","title":"The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; McGill University; Université de Montréal; University of Toronto; Cancer Care Ontario; Women's College Hospital","funders":"Canadian Cancer Society Research Institute","keywords":"Pancreatic cancer; Medicine; BRCA mutation; Germline mutation; Cancer; Internal medicine; Incidence (geometry); Oncology; BRCA2 Protein; Breast cancer; Mutation; Genetics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0198865648099765,"gpt":0.3595286960281431,"spread":0.3396421312181666,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008941112,0.00005687469,0.0003391156,0.00006345072,0.00006215552,0.0000134835,0.00006947275,0.00005560153,0.0001435864],"category_scores_gemma":[0.0004464974,0.00004466351,0.00004224587,0.0001432804,0.000221548,0.0001486925,0.00001769997,0.000260216,5.124456e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000180969,"about_ca_system_score_gemma":0.0005223993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003764008,"about_ca_topic_score_gemma":0.003026187,"domain_scores_codex":[0.9989163,0.00009255223,0.0003850518,0.00005919949,0.0003186161,0.0002283027],"domain_scores_gemma":[0.9990637,0.0002435711,0.0002310668,0.0000628708,0.0002492554,0.0001495427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001998258,0.00003267188,0.86912,0.00006942369,0.0001224129,0.0001013147,0.0007282817,0.000007885306,0.0006489975,0.00002520748,0.0004089847,0.128535],"study_design_scores_gemma":[0.001418561,0.0001263467,0.9932922,0.0009812271,0.0001765226,0.001391635,0.0006248253,0.0001015043,0.0003948906,0.0001084272,0.001338711,0.00004521985],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8936731,0.1049947,0.00002353595,0.0006289096,0.0001438374,0.0001337257,0.000006853026,0.000001461516,0.0003939496],"genre_scores_gemma":[0.9588473,0.04038578,0.0001535679,0.0001041849,0.0002198092,0.00001832031,3.01664e-7,0.000007532335,0.0002632452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1284898,"threshold_uncertainty_score":0.5690079,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992584926","doi":"10.1038/bjc.2013.6","title":"Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"CancerCare Manitoba; BC Cancer Agency","funders":"Public Health Agency; National Institute for Health and Care Research; Cancer Research UK; London School of Hygiene and Tropical Medicine","keywords":"Breast cancer; Medicine; Stage (stratigraphy); Population; Demography; Danish; Cancer registry; Cancer; Environmental health; Biology; Internal medicine; Sociology","retraction":null,"screen_n_in":null,"score":{"opus":0.04409165956299617,"gpt":0.327210861293424,"spread":0.2831192017304279,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004588214,0.000146198,0.0004685759,0.00006130878,0.0001195974,0.0001039807,0.0001107195,0.00005324312,0.004243577],"category_scores_gemma":[0.00006577681,0.0001195469,0.0000557788,0.0001682075,0.00007450629,0.000173313,0.00003959204,0.0003142431,0.000001717111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008484269,"about_ca_system_score_gemma":0.0007688822,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9821245,"about_ca_topic_score_gemma":0.9907553,"domain_scores_codex":[0.9982697,0.0001209006,0.0004956304,0.0001862278,0.0006360999,0.000291394],"domain_scores_gemma":[0.9989253,0.0001573512,0.000275463,0.0001013697,0.0003053353,0.000235164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004739512,0.00003522624,0.9783884,0.00002916857,0.00008991535,0.000373988,0.0001258917,0.0002678374,0.000005420864,0.00000135721,0.006672412,0.01353639],"study_design_scores_gemma":[0.005763094,0.00007862091,0.9913065,0.000706895,0.0001420086,0.0004801556,0.0006464667,0.00006998274,0.000007210224,0.00001085527,0.000656616,0.0001315579],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853709,0.01146799,0.000001504505,0.002126847,0.0002980916,0.0005144171,0.0001156385,0.000001799993,0.0001027961],"genre_scores_gemma":[0.9957485,0.001301059,0.00002594884,0.0006742261,0.0003390304,0.0001001779,0.000001609946,0.00001415923,0.001795277],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01340483,"threshold_uncertainty_score":0.9966667,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2170674868","doi":"10.1038/sj.bjc.6601150","title":"Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients","year":2003,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Axillary Lymph Node Dissection; Breast cancer; Sentinel lymph node; Biopsy; Lymph node; Axillary Dissection; Axilla; Dissection (medical); Quality of life (healthcare); Surgery; Mammary gland; Radiology; Cancer; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01262097681939547,"gpt":0.2985745248092951,"spread":0.2859535479898996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001695395,0.000159057,0.0005132661,0.00006178664,0.00004507295,0.0000144306,0.00008546182,0.00009871178,0.0000506829],"category_scores_gemma":[0.0000520889,0.0001689066,0.0001132891,0.0001170065,0.0001483657,0.00001535859,0.00004773762,0.0000783278,1.80335e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001037024,"about_ca_system_score_gemma":0.0001590077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002317149,"about_ca_topic_score_gemma":0.0004784194,"domain_scores_codex":[0.9984999,0.0001216652,0.000712169,0.0002088891,0.0002586528,0.0001986857],"domain_scores_gemma":[0.9987649,0.00001692391,0.0006152707,0.0001062524,0.0004042537,0.00009237492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001029264,0.0005724365,0.9893015,0.0001432285,0.0002497633,0.000007909533,0.00008790953,0.0001003287,0.00485316,0.000002052124,0.00009729084,0.003555134],"study_design_scores_gemma":[0.00352614,0.00002342811,0.9914212,0.0004213088,0.00005647244,0.0001461942,0.0001272555,0.000006883882,0.004011387,0.000009805826,0.00009466825,0.0001552052],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832529,0.01584253,0.00002710981,0.0001342831,0.0002613919,0.0000687819,0.0003322887,0.000001801049,0.00007886094],"genre_scores_gemma":[0.9957602,0.00381286,0.0001154395,0.0001499292,0.0001018102,0.00001780401,0.00001345375,0.00001848322,0.000009994581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01250727,"threshold_uncertainty_score":0.688781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035754366","doi":"10.1038/sj.bjc.6601327","title":"Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Matrix metalloproteinase; Extracellular matrix; Cell biology; Cancer research; Biology; Metastasis; Carcinogenesis; Cell migration; Cell adhesion; Cell growth; Matrix metalloproteinase inhibitor; Cancer cell; Cancer; Cell; Biochemistry; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0129541512249053,"gpt":0.288102276808041,"spread":0.2751481255831357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002709659,0.0003876971,0.001035124,0.00009279563,0.0001377383,0.00009644724,0.0002178156,0.0003061814,0.00008814836],"category_scores_gemma":[0.00002408709,0.0003454913,0.0003071924,0.0001043113,0.00004470808,0.00001332663,0.0001097441,0.0003253885,0.00000192216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000102815,"about_ca_system_score_gemma":0.0008028253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009181869,"about_ca_topic_score_gemma":0.0001414635,"domain_scores_codex":[0.9982226,0.000141901,0.0007508507,0.0003555182,0.0002071184,0.0003219897],"domain_scores_gemma":[0.9987279,0.000007666353,0.0007782562,0.0001422158,0.0001630456,0.0001809446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001753893,0.0000444229,0.000002479813,0.004040456,0.0004156599,0.0001519915,0.00001679702,0.000002622707,0.02362643,5.014971e-7,0.0009261277,0.970755],"study_design_scores_gemma":[0.0002500293,0.00005582595,0.000001317583,0.007146656,0.0001764853,0.0006119263,0.000006680561,2.956774e-8,0.3180057,0.00000317607,0.6734527,0.000289424],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006438604,0.9922754,0.0000261287,0.000005299611,0.0005745885,0.0004158574,0.000101326,0.000005176546,0.0001576474],"genre_scores_gemma":[0.0009231903,0.9956129,0.0003566249,0.00003008071,0.0009288876,0.0001464183,0.00001738459,0.0000773383,0.001907159],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9704655,"threshold_uncertainty_score":0.9998997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2622052156","doi":"10.1038/bjc.2017.149","title":"Subcutaneous adiposity is an independent predictor of mortality in cancer patients","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Adipose tissue; Sarcopenia; Hazard ratio; Internal medicine; Proportional hazards model; Body mass index; Cachexia; Obesity; Obesity paradox; Cancer; Univariate analysis; Gastroenterology; Oncology; Multivariate analysis; Confidence interval; Overweight","retraction":null,"screen_n_in":null,"score":{"opus":0.05080834291670903,"gpt":0.386006950472817,"spread":0.3351986075561079,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000277953,0.00007445933,0.000372428,0.00007364617,0.0001024131,0.00003667008,0.0001700074,0.0000783842,0.0005319961],"category_scores_gemma":[0.00005961547,0.00008190097,0.00008004825,0.00003895435,0.00007603708,0.0002242593,0.00002586302,0.0003559758,5.450714e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002351747,"about_ca_system_score_gemma":0.0003409358,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01024584,"about_ca_topic_score_gemma":0.01059868,"domain_scores_codex":[0.9985979,0.00003710952,0.0005622206,0.0001212726,0.000497441,0.0001840786],"domain_scores_gemma":[0.9984366,0.000009078453,0.0006604149,0.0001671158,0.0004929948,0.0002338434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003272652,0.000442448,0.9647321,0.0002261138,0.00006067187,0.0004594402,0.0002116347,0.000003069169,0.0001981412,0.000002959498,0.0008936043,0.03244255],"study_design_scores_gemma":[0.003356336,0.0003395973,0.9912779,0.002129354,0.00008624599,0.0003096944,0.00002200331,0.00002641064,0.0007567278,0.00009610113,0.001530527,0.00006913687],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939188,0.004262139,0.000003429998,0.0005132039,0.0006462521,0.0001772636,0.0001514908,0.000003986971,0.0003234305],"genre_scores_gemma":[0.9934143,0.005392453,0.00008022973,0.0006528592,0.0003484139,0.000006479678,0.000002572516,0.00001173312,0.00009094332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03237342,"threshold_uncertainty_score":0.996345,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2344227124","doi":"10.1038/bjc.2015.415","title":"Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"National Institutes of Health; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Cohort; Cancer; Cohort study; Internal medicine; Nuclear medicine; Oncology; Pathology; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.03708775939288934,"gpt":0.3742545439841418,"spread":0.3371667845912524,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004563345,0.00005880773,0.0002672777,0.0001156401,0.00005544699,0.00001128352,0.00005106204,0.00002314262,0.00004510571],"category_scores_gemma":[0.0003889719,0.00003988181,0.0001116421,0.0001700053,0.0001411659,0.0001874848,0.00001355423,0.0001612497,4.182348e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001387716,"about_ca_system_score_gemma":0.0005498643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008407519,"about_ca_topic_score_gemma":0.00007083839,"domain_scores_codex":[0.9990585,0.0001051856,0.0004480612,0.0000641945,0.0002339317,0.0000900559],"domain_scores_gemma":[0.9984708,0.0004554593,0.0007421711,0.00007293222,0.0001761715,0.00008239475],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000008634873,0.00001760238,0.9802793,0.0000362905,0.0001125768,0.000005414498,0.00005782439,0.00007205854,0.001617844,0.00002460041,0.0005981268,0.01716979],"study_design_scores_gemma":[0.00157976,0.0001216276,0.9955231,0.0008774786,0.0002951146,0.0002865512,0.0000758471,0.00003086509,0.0007163636,0.0004365699,0.00001558324,0.00004113882],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937273,0.004672131,0.0003867266,0.0007465156,0.00004022204,0.0001070721,0.0002109906,0.000001650518,0.0001073828],"genre_scores_gemma":[0.9979796,0.001756377,0.0001078368,0.00001967558,0.00009237847,0.000001555347,0.000001444473,0.000008028707,0.00003308101],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01712865,"threshold_uncertainty_score":0.1626333,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082067798","doi":"10.1038/sj.bjc.6602902","title":"mTOR signaling: implications for cancer and anticancer therapy","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research Society; McGill University; Howard Hughes Medical Institute","keywords":"PI3K/AKT/mTOR pathway; EIF4E; Carcinogenesis; Translation (biology); Cancer research; Biology; RPTOR; Sirolimus; Signal transduction; Cancer; Cell biology; Genetics; Gene; Messenger RNA; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02103277796690395,"gpt":0.3267986203172294,"spread":0.3057658423503255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000231125,0.0001349341,0.0002241313,0.00003914515,0.0001199424,0.00007128492,0.0002609048,0.0001129581,0.000109734],"category_scores_gemma":[0.00006913779,0.0001458971,0.0001391288,0.00007319523,0.0001007169,0.00001711936,0.00003639502,0.0001273798,4.247671e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006924337,"about_ca_system_score_gemma":0.0003549983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001005327,"about_ca_topic_score_gemma":0.0004573167,"domain_scores_codex":[0.9989891,0.00002285699,0.0003602126,0.0002347691,0.0001373114,0.0002557542],"domain_scores_gemma":[0.9989223,0.00002595676,0.0002896744,0.0001504494,0.0004805374,0.0001310551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002011126,0.00005266483,0.006312959,0.00001768395,0.0002207497,0.000001847158,0.00003247281,0.0004548546,0.4866892,0.00002467407,0.0188731,0.4871187],"study_design_scores_gemma":[0.002034902,0.0002675569,0.01387802,0.0001684488,0.00006725489,0.000197587,0.00001602805,0.00002999387,0.1999214,0.0002300645,0.782921,0.0002678003],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8226721,0.1710613,0.001799851,0.003560061,0.0003890619,0.0002200438,0.0002111832,0.000006758001,0.00007966544],"genre_scores_gemma":[0.93542,0.05551787,0.003166083,0.001763629,0.003535459,0.0001366941,0.000007988217,0.00004653723,0.0004056905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7640479,"threshold_uncertainty_score":0.5949509,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002561481","doi":"10.1038/bjc.2011.120","title":"Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; Women's College Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oophorectomy; Cancer; Internal medicine; Oncology; Family history; BRCA mutation; Mastectomy; Gynecology; Prophylactic Surgery; First-degree relatives; Obstetrics; Surgery; Hysterectomy","retraction":null,"screen_n_in":null,"score":{"opus":0.007360750393747948,"gpt":0.2485913111956694,"spread":0.2412305608019215,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001525588,0.00008227246,0.0001727454,0.00006166199,0.00002353715,0.00001379026,0.0001059023,0.00009029474,0.0001533507],"category_scores_gemma":[0.00002152803,0.00009420269,0.00005703328,0.00008389627,0.0001257408,0.0000173061,0.00002196058,0.0001092868,9.624882e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008393843,"about_ca_system_score_gemma":0.0003446803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001636879,"about_ca_topic_score_gemma":0.003447427,"domain_scores_codex":[0.9991923,0.00004187511,0.0003559207,0.0001334455,0.0001327693,0.0001437167],"domain_scores_gemma":[0.9993454,0.000004826637,0.0002582833,0.00006833504,0.0002510884,0.00007208618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000690654,0.0000975749,0.724772,0.00008443047,0.0005985713,0.0001434546,0.001799898,0.001087637,0.08172437,0.00001357599,0.002145028,0.1868428],"study_design_scores_gemma":[0.001754542,0.0001279482,0.9518339,0.0002411074,0.00006400191,0.001028973,0.0002081913,0.00002450402,0.04321264,0.0000723842,0.00129266,0.0001391489],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.983337,0.01563519,0.00006069817,0.000077594,0.0004616994,0.00008083449,0.0002057711,0.000001625098,0.0001395866],"genre_scores_gemma":[0.9941244,0.005252455,0.0001987557,0.00008583708,0.0002499327,0.0000132565,0.000003891961,0.00001560158,0.00005587355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2270619,"threshold_uncertainty_score":0.3841474,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896626889","doi":"10.1038/s41416-018-0274-8","title":"Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"NuCana; Myriad Genetics; AstraZeneca","keywords":"Olaparib; PARP inhibitor; Ovarian cancer; Medicine; BRCA mutation; Oncology; Cancer; Internal medicine; Cancer research; Population; Biology; Genetics; Gene; Poly ADP ribose polymerase; Polymerase","retraction":null,"screen_n_in":null,"score":{"opus":0.01504631600092651,"gpt":0.313716842631745,"spread":0.2986705266308185,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009004564,0.0001480129,0.0004815355,0.0001538569,0.00009367549,0.00003334106,0.0001186816,0.0001011827,0.0007710282],"category_scores_gemma":[0.00005839038,0.0001282744,0.000163391,0.0004282254,0.000467128,0.0001765586,0.00002958883,0.0003341972,0.000002494525],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003639201,"about_ca_system_score_gemma":0.0008950224,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.007931285,"about_ca_topic_score_gemma":0.02932162,"domain_scores_codex":[0.9981502,0.0001557783,0.0006886569,0.0001840256,0.0005216114,0.0002997092],"domain_scores_gemma":[0.9983498,0.00008162407,0.0005594117,0.0001856707,0.00067841,0.0001450953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003757987,0.0003305388,0.1920993,0.0001834514,0.001206312,0.00154077,0.001529906,0.00009157894,0.3214642,0.00004997272,0.05328311,0.4244629],"study_design_scores_gemma":[0.0119394,0.000583794,0.497753,0.005299934,0.0003465522,0.004855621,0.0004628857,0.0001365759,0.3977101,0.0004907819,0.0799904,0.0004309601],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9634944,0.02883145,0.0001291399,0.004763065,0.001522356,0.0002622558,0.0001603989,0.00000797019,0.0008289769],"genre_scores_gemma":[0.9842169,0.01146018,0.0002401374,0.001663094,0.002219026,0.00002145765,0.000002349114,0.00003053467,0.0001463783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4240319,"threshold_uncertainty_score":0.998675,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2761998606","doi":"10.1038/bjc.2017.334","title":"International consensus guidelines for scoring the histopathological growth patterns of liver metastasis","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Metastasis; Consensus conference; Pathology; Medicine; MEDLINE; Cancer; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.227342489823958,"gpt":0.3709829245067371,"spread":0.1436404346827792,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004189726,0.00006857686,0.0002529987,0.00003574457,0.0001206411,0.00004765701,0.0001934206,0.0000363645,0.0001747845],"category_scores_gemma":[0.0007283819,0.00004885588,0.0002540767,0.00001337094,0.00008015081,0.00005855756,0.0000343258,0.0001038845,5.113468e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005028336,"about_ca_system_score_gemma":0.00007942315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006613779,"about_ca_topic_score_gemma":0.0001315078,"domain_scores_codex":[0.9991777,0.00002653116,0.0003741207,0.00008402986,0.0002371369,0.0001005116],"domain_scores_gemma":[0.9980999,0.00006574207,0.0004688315,0.0001076609,0.001201469,0.00005639331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002313756,0.00007096928,0.7708801,0.00005585606,0.0002912793,0.001106083,0.00004609864,0.00000101359,0.0008108849,0.00004963855,0.004741321,0.2217153],"study_design_scores_gemma":[0.004208,0.0004458173,0.9079937,0.001385853,0.001119868,0.005275746,0.0000896339,0.0003307951,0.01287636,0.0001683535,0.06596155,0.0001442915],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803945,0.01048927,0.0004388657,0.007502428,0.0005566434,0.0001870446,0.0001042259,0.000003551815,0.0003234297],"genre_scores_gemma":[0.9909725,0.005028825,0.002795695,0.0002366034,0.0006773017,0.00001514029,0.000002643714,0.000009316052,0.0002619325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2215711,"threshold_uncertainty_score":0.1992285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076480857","doi":"10.1038/sj.bjc.6605154","title":"Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Natural Science Foundation of Heilongjiang Province; Fondation pour la Recherche Médicale; National Natural Science Foundation of China","keywords":"RHOA; PI3K/AKT/mTOR pathway; Protein kinase B; Focal adhesion; Fibronectin; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Cell migration; Biology; Cell biology; Signal transduction; Chemistry; Extracellular matrix; Cell; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01806156981019608,"gpt":0.2898003174253042,"spread":0.2717387476151081,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000319045,0.00007808887,0.0002768348,0.0001379775,0.00002856548,0.00002646453,0.00005244485,0.00007849051,0.0002494777],"category_scores_gemma":[0.000108648,0.00008316636,0.00005524025,0.0001808542,0.00002333772,0.0002002233,0.0000118551,0.0002757107,4.068518e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002191289,"about_ca_system_score_gemma":0.0002710442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001989034,"about_ca_topic_score_gemma":0.002062751,"domain_scores_codex":[0.9987511,0.0000618491,0.0004845526,0.0001205547,0.0004272447,0.0001547147],"domain_scores_gemma":[0.9991387,0.00005768578,0.0003187605,0.00005068652,0.000321763,0.0001124562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002971045,0.000104162,0.03363295,0.000157692,0.00001379676,0.0001619115,0.0003498817,0.00008330468,0.8599522,6.58818e-7,0.000246814,0.1049996],"study_design_scores_gemma":[0.002663736,0.0004444607,0.7862502,0.002656803,0.00005058015,0.0002035117,0.0001582366,0.002304987,0.2046821,0.00002246309,0.000451919,0.0001109646],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774292,0.02165492,0.00007783334,0.0004649296,0.00006458423,0.0001917081,0.00001048922,0.00000425669,0.0001021523],"genre_scores_gemma":[0.9631853,0.03624678,0.0001900937,0.0001486845,0.0001400677,0.000004488075,0.000008817964,0.00001095104,0.0000648911],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7526173,"threshold_uncertainty_score":0.3391426,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003411025","doi":"10.1038/sj.bjc.6603127","title":"Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"University of Nottingham","keywords":"Medicine; Gallbladder cancer; Gallbladder; Biliary tract; Gastroenterology; Intrahepatic bile ducts; Liver cancer; Bile duct; Internal medicine; Cancer registry; Incidence (geometry); Cancer; Bile duct cancer; Intrahepatic Cholangiocarcinoma; Population","retraction":null,"screen_n_in":null,"score":{"opus":0.01939358657532278,"gpt":0.2717813328617017,"spread":0.2523877462863789,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003597479,0.00008624067,0.0003491297,0.0001698154,0.00002714211,0.00001848136,0.00006291843,0.00004205669,0.00002817506],"category_scores_gemma":[0.00002573475,0.0000693224,0.00005112603,0.000218684,0.000145155,0.0001360117,0.00001924049,0.0002515,4.125964e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00014213,"about_ca_system_score_gemma":0.0001548514,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02301504,"about_ca_topic_score_gemma":0.07619144,"domain_scores_codex":[0.9990994,0.00004942131,0.0003463328,0.0001116569,0.000237285,0.0001559098],"domain_scores_gemma":[0.9995892,0.00009564473,0.0001495817,0.00005696083,0.00006833348,0.0000402947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000155032,0.00005785136,0.7449203,0.00008182293,0.00002235329,0.001030699,0.001245417,0.00001171156,0.0002177529,0.000001608317,0.001500349,0.2507551],"study_design_scores_gemma":[0.002545203,0.0001455745,0.9899701,0.0007880891,0.00006883436,0.002442065,0.0002476964,0.00001174893,0.00006313021,0.00003678165,0.003611263,0.00006951207],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8270968,0.1715305,8.54095e-7,0.0005590726,0.00005454771,0.00006176347,0.00001184137,0.000001408758,0.0006831418],"genre_scores_gemma":[0.9657435,0.03360684,0.00006332561,0.0002586067,0.0002303423,0.000006199654,0.000001430193,0.00000692882,0.00008281774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2506856,"threshold_uncertainty_score":0.9834908,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963500271","doi":"10.1054/bjoc.2001.2165","title":"Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Supratek Pharma (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Sensitization; Poloxamer; Copolymer; Mechanism (biology); Cancer; Chemistry; Block (permutation group theory); Cancer research; Medicine; Immunology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.005091498015092187,"gpt":0.2324784544535491,"spread":0.227386956438457,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001446977,0.0001231875,0.0004822202,0.0001119803,0.00004200185,0.000008153043,0.000074096,0.0001156108,0.0003570259],"category_scores_gemma":[0.00000936646,0.0001302482,0.0001678317,0.0002819952,0.0000626808,0.0001024743,0.000006157235,0.0001702642,3.28212e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001642579,"about_ca_system_score_gemma":0.0003866127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00229995,"about_ca_topic_score_gemma":0.002342054,"domain_scores_codex":[0.9985597,0.00003935814,0.0005736471,0.000139158,0.0004789486,0.0002092416],"domain_scores_gemma":[0.9985144,0.00002078872,0.0006070984,0.0000773823,0.0006645966,0.0001157394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000829611,0.0002764989,0.001005398,0.0001983579,0.0004531889,0.0002731291,0.00020594,0.0004240641,0.9664526,0.0003502374,0.003272768,0.02625822],"study_design_scores_gemma":[0.002681141,0.0003414987,0.001409706,0.001829949,0.0004668849,0.0006300574,0.0001368682,0.000144727,0.9873668,0.000368214,0.004469858,0.0001543062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.940883,0.0454447,0.01084193,0.0006003313,0.0009240337,0.0002140678,0.0001492458,0.00001478556,0.0009278996],"genre_scores_gemma":[0.9591582,0.0391201,0.0001953636,0.0001796899,0.0002436569,0.000005445772,0.000009931979,0.00002980051,0.001057817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02610391,"threshold_uncertainty_score":0.5311366,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155863110","doi":"10.1038/sj.bjc.6604485","title":"The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance","year":2008,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Glutathione; Pancreatic cancer; Cystine; Oxidative stress; Biology; Cell growth; Cancer research; Cancer cell; Biochemistry; Pharmacology; Endocrinology; Cell biology; Cancer; Cysteine; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.003185424332191124,"gpt":0.2114012547527295,"spread":0.2082158304205383,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002436464,0.0001074672,0.0002759881,0.00002922672,0.0000673321,0.00001585164,0.0002163483,0.00005534112,0.00001233343],"category_scores_gemma":[0.00005846745,0.00008253544,0.00008170477,0.0001184879,0.000169285,0.00001104288,0.00002788306,0.0001541827,1.970024e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002576269,"about_ca_system_score_gemma":0.0004961648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001104591,"about_ca_topic_score_gemma":0.01235347,"domain_scores_codex":[0.9989212,0.00004714664,0.0004059582,0.0001364461,0.0002666786,0.0002226198],"domain_scores_gemma":[0.9990779,0.00001812942,0.0004085732,0.0001236301,0.0002953838,0.00007634768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004971416,0.0004468025,0.3892855,0.000476477,0.001292146,0.002000607,0.002276066,0.0004881774,0.4880444,0.0002133443,0.05970138,0.05080371],"study_design_scores_gemma":[0.005945805,0.0002246136,0.4463804,0.001881472,0.0002411591,0.002452654,0.0005260097,0.00001881843,0.2720864,0.0001995372,0.2694484,0.0005947112],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8521096,0.1471121,0.00003403024,0.0001718701,0.0001637893,0.00007422049,0.00003081416,0.000001638191,0.0003020261],"genre_scores_gemma":[0.8850741,0.1117062,0.0002331022,0.0000932467,0.0003229465,0.00001894566,0.000002019278,0.00001875181,0.002530694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.215958,"threshold_uncertainty_score":0.6893526,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052562958","doi":"10.1038/bjc.2013.372","title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Concordance; Medicine; Proportional hazards model; Oncology; Disease; Internal medicine; Bladder cancer; Hazard ratio; Cohort; Retrospective cohort study; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01312793185608517,"gpt":0.2676740225934418,"spread":0.2545460907373566,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001918612,0.0001437385,0.0004981108,0.0000592898,0.00007220762,0.00001785106,0.0003384055,0.0000627765,0.00006490749],"category_scores_gemma":[0.0003195117,0.00007925565,0.000250186,0.0002176028,0.000179482,0.0001562884,0.0001389121,0.0003007335,2.617664e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008960498,"about_ca_system_score_gemma":0.0007508529,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01700023,"about_ca_topic_score_gemma":0.004328006,"domain_scores_codex":[0.9984159,0.00008432152,0.0006326827,0.0001387345,0.0005270161,0.0002013134],"domain_scores_gemma":[0.9984918,0.0001193511,0.0006575549,0.0002954625,0.0003524491,0.00008333639],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001312818,0.0001447499,0.9607615,0.0001191534,0.0002586712,0.000007141177,0.001145576,0.001340833,0.008766248,0.000004249308,0.000892573,0.02642802],"study_design_scores_gemma":[0.002717781,0.0001421686,0.9640697,0.001954351,0.0003179726,0.00008074602,0.00027885,0.0001824734,0.02989601,0.0002263158,0.00006236999,0.00007126995],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940425,0.003388402,0.0000246208,0.0008256069,0.0003347602,0.0008329737,0.0002613672,0.000001598927,0.0002881776],"genre_scores_gemma":[0.9972831,0.001824038,0.0001067697,0.0003263266,0.0001250475,0.0000353085,1.812637e-7,0.00002272651,0.0002764981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02635675,"threshold_uncertainty_score":0.9895456,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2342252157","doi":"10.1038/bjc.2016.79","title":"Hypoxia-activated prodrugs: paths forward in the era of personalised medicine","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prodrug; Hypoxia (environmental); Drug; Pharmacology; Tumor hypoxia; Cancer research; Tirapazamine; Effector; Biology; Medicine; Immunology; Internal medicine; In vitro; Cytotoxicity; Chemistry; Radiation therapy; Biochemistry; Oxygen","retraction":null,"screen_n_in":null,"score":{"opus":0.01965660309295139,"gpt":0.3163151735600061,"spread":0.2966585704670547,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007864175,0.0002702356,0.001340995,0.00008898709,0.00003820788,0.00002072431,0.0005598174,0.0002723812,0.000143141],"category_scores_gemma":[0.0002528996,0.0001740424,0.0005590676,0.0002114112,0.0001849906,0.000009647013,0.00004529084,0.0005116269,8.687908e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005532488,"about_ca_system_score_gemma":0.0009453406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002482253,"about_ca_topic_score_gemma":0.0002919119,"domain_scores_codex":[0.9977954,0.0002838964,0.0009588031,0.0002559542,0.0004335266,0.0002724311],"domain_scores_gemma":[0.9981031,0.000053125,0.001170752,0.0002487304,0.0003350129,0.00008928659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005819484,0.00004259418,0.000002901642,0.001175577,0.000253947,0.00002619259,0.00008337806,4.082034e-7,0.001912001,0.000003927094,0.01483321,0.9816077],"study_design_scores_gemma":[0.001152804,0.000148314,0.00008297004,0.02170109,0.0003914235,0.00102204,0.00007041575,5.330192e-8,0.0002321146,0.00001885921,0.9749802,0.0001997531],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001175392,0.9964265,0.00001480729,0.0002001775,0.001292838,0.0003819178,0.0001921936,0.00000170839,0.0003144845],"genre_scores_gemma":[0.0006124019,0.9933584,0.00003417141,0.0002096799,0.005329524,0.00005684155,0.00002833851,0.00004447903,0.000326149],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9814079,"threshold_uncertainty_score":0.7097245,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}